piretanide has been researched along with Electrolytes in 16 studies
piretanide: potent inhibitor of chloride transport; structure
Electrolytes: Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed)
Excerpt | Relevance | Reference |
---|---|---|
"In a randomized double-blind, parallel group study, the effects of piretanide on serum electrolytes and on symptoms of congestive heart failure were compared with those of the combination piretanide plus triamterene in out-patients with mild to severe congestive heart failure." | 9.05 | The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure. ( Bückert, C; Freude, J; Jaeger, S; Pahnke, K; Verho, M, 1985) |
" The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure." | 7.67 | Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988) |
"The haemodynamic effect of a single 12 mg intravenous dose of piretanide was assessed in 11 patients with congestive heart failure." | 7.66 | Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure. ( Apoil, E; Hébert, JL; Valette, H, 1983) |
"Piretanide presented in 6 mg sustained-release capsules was administered twice daily for 12 weeks as antihypertensive monotherapy to 16 patients with mild-to-moderate hypertension." | 7.66 | Piretanide in the treatment of hypertension. Effects on arterial blood pressure and several blood variables. ( Leary, WP; Reyes, AJ, 1981) |
" The purpose of the present study was to examine whether long-term therapy with ramipril (RA, and ACE inhibitor) would lower blood pressure more effectively and without adverse reactions in combination with the loop diuretics piretanide (PI) or furosemide (FU)." | 5.28 | Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats. ( Baldes, L; Becker, RH; Treudler, M, 1989) |
"In a randomized double-blind, parallel group study, the effects of piretanide on serum electrolytes and on symptoms of congestive heart failure were compared with those of the combination piretanide plus triamterene in out-patients with mild to severe congestive heart failure." | 5.05 | The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure. ( Bückert, C; Freude, J; Jaeger, S; Pahnke, K; Verho, M, 1985) |
" The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure." | 3.67 | Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988) |
"The haemodynamic effect of a single 12 mg intravenous dose of piretanide was assessed in 11 patients with congestive heart failure." | 3.66 | Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure. ( Apoil, E; Hébert, JL; Valette, H, 1983) |
"Piretanide presented in 6 mg sustained-release capsules was administered twice daily for 12 weeks as antihypertensive monotherapy to 16 patients with mild-to-moderate hypertension." | 3.66 | Piretanide in the treatment of hypertension. Effects on arterial blood pressure and several blood variables. ( Leary, WP; Reyes, AJ, 1981) |
"Piretanide is a new diuretic agent that is structurally related to bumetanide and furosemide." | 2.65 | [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses]. ( Fink, R; Heuer, LJ; Machnik, H; Studt, J, 1983) |
" The purpose of the present study was to examine whether long-term therapy with ramipril (RA, and ACE inhibitor) would lower blood pressure more effectively and without adverse reactions in combination with the loop diuretics piretanide (PI) or furosemide (FU)." | 1.28 | Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats. ( Baldes, L; Becker, RH; Treudler, M, 1989) |
"Hydroxy propyl cellulose (HPC)-ethyl cellulose (EC) microcapsules containing piretanide were newly by a solvent evaporation technique and their slow-release properties were evaluated on dissolution properties in vitro and pharmacokinetic and pharmacodynamic parameters in beagle dogs." | 1.28 | Preparation and pharmacokinetic and pharmacodynamic evaluation of hydroxy propyl cellulose-ethyl cellulose microcapsules containing piretanide. ( Goto, S; Kawata, M; Suzuki, N; Tsujiyama, T; Uchida, T, 1989) |
" In a dosage of 2 to 3 mg, it induced an increase in sodium excretion of almost 13% of filtered load, and there was an associated 2- to 3-fold increase in potassium excretion." | 1.26 | Acute effects of piretanide in normal subjects. ( Puschett, JB; Teredesai, P, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (93.75) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heuer, LJ | 1 |
Machnik, H | 1 |
Studt, J | 1 |
Fink, R | 1 |
McNabb, WR | 2 |
Noormohamed, FH | 2 |
Brooks, BA | 1 |
Lant, AF | 2 |
Valette, H | 1 |
Hébert, JL | 1 |
Apoil, E | 1 |
Odlind, B | 1 |
Beermann, B | 1 |
Selén, G | 1 |
Persson, AE | 1 |
Radaelli, L | 1 |
Cosci, P | 1 |
Grillo, C | 1 |
Bertoli, S | 1 |
Minetti, L | 1 |
Henderson, IS | 1 |
Beattie, TJ | 1 |
Kennedy, AC | 1 |
Dombey, SL | 1 |
Hadj Aissa, A | 1 |
Pozet, N | 2 |
Labeeuw, M | 1 |
Pellet, M | 2 |
Traeger, J | 2 |
Leary, WP | 1 |
Reyes, AJ | 1 |
Hadj-Aissa, A | 1 |
Prestel, R | 1 |
Storck, M | 1 |
Pooth, R | 1 |
Steinbach, G | 1 |
Hammer, C | 1 |
Abendroth, D | 1 |
Teredesai, P | 1 |
Puschett, JB | 1 |
Becker, RH | 1 |
Baldes, L | 1 |
Treudler, M | 1 |
Tsujiyama, T | 1 |
Suzuki, N | 1 |
Kawata, M | 1 |
Uchida, T | 1 |
Goto, S | 1 |
Verho, M | 1 |
Bückert, C | 1 |
Freude, J | 1 |
Jaeger, S | 1 |
Pahnke, K | 1 |
Ansuini, R | 1 |
Pulido, M | 1 |
Pupita, G | 1 |
Gaggi, S | 1 |
Pupita, F | 1 |
2 trials available for piretanide and Electrolytes
Article | Year |
---|---|
[Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
Topics: Aged; Creatinine; Diuretics; Electrolytes; Female; Furosemide; Humans; Kidney Diseases; Male; Middle | 1983 |
The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuretics; Double-Blind Method; | 1985 |
14 other studies available for piretanide and Electrolytes
Article | Year |
---|---|
Renal actions of piretanide and three other "loop" diuretics.
Topics: Absorption; Adult; Body Water; Bumetanide; Diuretics; Electrolytes; Ethacrynic Acid; Furosemide; Hem | 1984 |
Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Diuretics; Electrolytes; Female; Heart Failure; Hemodynam | 1983 |
Renal tubular secretion of piretanide and its effects on electrolyte reabsorption and tubuloglomerular feedback mechanism.
Topics: Diuretics; Electrolytes; Feedback; Humans; Kidney Glomerulus; Kidney Tubules; Loop of Henle; Nephron | 1983 |
[Evaluation of the antihypertensive effect of the new saluretic drug, piretanide].
Topics: Adult; Diuretics; Electrolytes; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Sulfo | 1982 |
Oral piretanide in chronic renal failure.
Topics: Adult; Aged; Bumetanide; Diuretics; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Hu | 1982 |
Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiency.
Topics: Adult; Diuretics; Electrolytes; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, | 1981 |
Piretanide in the treatment of hypertension. Effects on arterial blood pressure and several blood variables.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Evaluation; Electrolytes; | 1981 |
Activity of a new high efficiency diuretic in man: piretanide (HOE 118).
Topics: Adult; Aged; Blood Pressure; Diuretics; Electrolytes; Glomerular Filtration Rate; Humans; Middle Age | 1980 |
Na-K/2Cl transporter inhibition for reduction of postischemic kidney failure tested in autologous reperfusion.
Topics: Animals; Blood Glucose; Carrier Proteins; Diuretics; Electrolytes; Ischemia; Kidney; Kidney Transpla | 1996 |
Acute effects of piretanide in normal subjects.
Topics: Diuretics; Electrolytes; Humans; Hydrogen-Ion Concentration; Kidney; Male; Regional Blood Flow; Sulf | 1979 |
Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bridged | 1989 |
Preparation and pharmacokinetic and pharmacodynamic evaluation of hydroxy propyl cellulose-ethyl cellulose microcapsules containing piretanide.
Topics: Animals; Capsules; Cellulose; Delayed-Action Preparations; Diuretics; Dogs; Electrolytes; Male; Micr | 1989 |
Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
Topics: Adult; Aged; Diuretics; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middl | 1988 |
Clinical pharmacology of loop diuretics: a comparative study.
Topics: Adult; Ascites; Blood Pressure; Body Weight; Bumetanide; Diuresis; Diuretics; Electrolytes; Female; | 1985 |